exactly, its a supply and demand issue, with the only trumps card being CB dishoarding, but even that is doing little thus far to pacify the raging bull.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling